Collection 24 September 2019

Editor's Highlights from npj Breast Cancer

Explore our collection of research highlights from npj Breast Cancer, curated by Editor-in-Chief Dr. Larry Norton, Medical Director of the Evelyn H. Lauder Breast Center at Memorial Sloan Kettering Cancer Center. The collection includes articles on diagnostics, cancer genetics and genomics, metastasis, treatment, and more.

Research Highlights

Somatic mutations in leukocytes infiltrating primary breast cancers
- Maria Kleppe
- Elizabeth Comen
- Larry Norton
ArticleOpen Access10 Jun 2015 npj Breast Cancer
MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer
- Stephen Johnston
- Miguel Martin
- Matthew P. Goetz
ArticleOpen Access17 Jan 2019 npj Breast Cancer
Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancers
- Floris H. Groenendijk
- Tina Treece
- Pat Whitworth
ArticleOpen Access18 Apr 2019 npj Breast Cancer
LobSig is a multigene predictor of outcome in invasive lobular carcinoma
- Amy E. McCart Reed
- Samir Lal
- Peter T. Simpson
ArticleOpen Access27 Jun 2019 npj Breast Cancer
FGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtype
- Kevin M. Levine
- Nolan Priedigkeit
- Steffi Oesterreich
Brief CommunicationOpen Access27 Jun 2019 npj Breast Cancer
Heterocellular gene signatures reveal luminal-A breast cancer heterogeneity and differential therapeutic responses
- Pawan Poudel
- Gift Nyamundanda
- Anguraj Sadanandam
ArticleOpen Access2 Aug 2019 npj Breast Cancer
Homologous recombination DNA repair defects in PALB2-associated breast cancers
- Anqi Li
- Felipe C. Geyer
- kConFab Investigators
ArticleOpen Access8 Aug 2019 npj Breast Cancer
Metabolomic analysis of serum may refine 21-gene expression assay risk recurrence stratification
- Amelia McCartney
- Alessia Vignoli
- Angelo Di Leo
Brief CommunicationOpen Access29 Aug 2019 npj Breast Cancer
Image analysis with deep learning to predict breast cancer grade, ER status, histologic subtype, and intrinsic subtype
- Heather D. Couture
- Lindsay A. Williams
- Marc Niethammer
ArticleOpen Access3 Sep 2018 npj Breast Cancer
NF1 deficiency correlates with estrogen receptor signaling and diminished survival in breast cancer
- Patrick S. Dischinger
- Elizabeth A. Tovar
- Matthew R. Steensma
ArticleOpen Access30 Aug 2018 npj Breast Cancer

Editor's Highlights from npj Breast Cancer

Research Highlights

Somatic mutations in leukocytes infiltrating primary breast cancers

MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer

Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancers

LobSig is a multigene predictor of outcome in invasive lobular carcinoma

FGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtype

Heterocellular gene signatures reveal luminal-A breast cancer heterogeneity and differential therapeutic responses

Homologous recombination DNA repair defects in PALB2-associated breast cancers

Metabolomic analysis of serum may refine 21-gene expression assay risk recurrence stratification

Image analysis with deep learning to predict breast cancer grade, ER status, histologic subtype, and intrinsic subtype

NF1 deficiency correlates with estrogen receptor signaling and diminished survival in breast cancer

Search

Quick links